Cuban Deputy Prime Minister Ricardo Cabrisas leads a delegation on a visit to BIOTECH PHARMACEUTICAL CO., LTD.-BIOTECH PHARMACEUTICAL CO., LTD_EGF Vaccine

Home
About Us
About Us

BPL is a high-tech China-Cuba joint venture among first group engaged in the development, production and sales of monoclonal antibodies in China.
S&T
S&T

International-standard humanized monoclonal antibody preparation processes and large-scale, continuous mammalian cell culture technology.
- Research Areas
- Technology Platforms
Research and Development
Research and Development

China has developed nivolumab, a humanized monoclonal antibody drug (trade name: TaiXinSheng), for the treatment of malignant tumors.
Blog
Blog

Integrating industry-related media coverage as well as the company’s various activities and updates.
- Company News
- Media Reports
Join Us
Join Us

Boasting a postdoctoral research workstation and diverse career opportunities, we sincerely invite talented individuals from all fields to join Baite.
- Post-Doctoral Center
Contact Us
Contact Us

ThaiXinLife Consultation Hotline: +86 4006592330
Company Main Line: +86-10-51571020
- Contact Us

中

Company News

Media News

Cuban Deputy Prime Minister Ricardo Cabrisas leads a delegation on a visit to BIOTECH PHARMACEUTICAL CO., LTD.

Category:

Blog

Company News

Author:

Source:

Release date:

2023-10-18

On October 17, 2023, Ricardo Cabrisas, Cuba's Deputy Prime Minister and Minister of Foreign Trade and Foreign Investment, led a delegation on a visit to BIOTECH PHARMACEUTICAL CO., LTD. Cuban Ambassador to China, Bai Shide, along with Deborah Rivas, Deputy Minister of Foreign Trade and Foreign Investment; Carlos Jorge, Director of the Department of Foreign Investment at Cuba’s Ministry of Foreign Trade and Foreign Investment; Ernesto Vega, Director of the Planning Department at Cuba’s Ministry of Economy and Planning; and Vilma Sanchez, Director of Asian and Oceania Trade Policy at Cuba’s Ministry of Foreign Trade and Foreign Investment, participated fully in the event.

Bai Xianhong, Chairman and General Manager of Biotech Pharma, along with Vice Presidents Lin Feng and Li Xianzhong, engaged in a warm and friendly conversation with the delegation.

The delegation visited Biotech Pharma's production facilities.

Bai Xianhong, Chairman and General Manager of Biotech Pharma, presented an overview of the company's business development.

Vice Premier Ricardo Cabrisas stated that Biotech Pharma is a shining example of China-Cuba cooperation, having garnered significant attention from leaders in both countries since its inception. Biotech Pharma has achieved remarkable success, and Cuba will continue to firmly support its development as always. We sincerely hope that Biotech Pharma will further strengthen biotechnology collaboration between China and Cuba, while also contributing even more to improving the health standards of our respective peoples.